Related Experiment Video

Updated: Oct 30, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.2K

PDLIM2 Suppression Inhibit Proliferation and Metastasis in Kidney Cancer

Hyeong-Dong Yuk1,2, Kyoung-Hwa Lee3, Hye-Sun Lee1

  • 1Department of Urology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.

Cancers
|July 2, 2021
PubMed

Insights

PDLIM2 protein is highly expressed in metastatic kidney cancers and drives tumor formation and spread. Inhibiting PDLIM2 reduced cancer cell proliferation and metastasis, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Kidney cancer metastasis remains a significant clinical challenge.
  • Understanding the molecular drivers of metastasis is crucial for developing effective therapies.
  • PDLIM2 (PDZ and LIM domain 2) role in kidney cancer progression is not well-defined.

Purpose of the Study:

  • To investigate the role of PDLIM2 in kidney cancer formation and metastasis.
  • To evaluate PDLIM2 as a potential therapeutic target for metastatic kidney cancer.

Main Methods:

  • Assessed PDLIM2 expression in human kidney cancer cell lines of primary and metastatic origin.
  • Utilized RNA interference (RNAi) to inhibit PDLIM2 expression in metastatic kidney cancer cells.
  • Developed and utilized metastatic-prone mouse kidney cancer cell lines through orthotopic injection.
  • Examined tumor formation and metastasis in PDLIM2 knockout mice using experimental and orthotopic metastasis models.

Main Results:

  • PDLIM2 expression was significantly elevated in metastatic kidney cancers compared to primary ones.
  • PDLIM2 knockdown in human metastatic kidney cancer cells led to decreased proliferation and metastatic potential.
  • Metastatic-prone mouse kidney cancer cell lines exhibited higher PDLIM2 expression than parental cells.
  • PDLIM2 knockout mice showed significantly reduced lung metastasis in both experimental and orthotopic models compared to control mice.

Conclusions:

  • PDLIM2 is essential for kidney cancer formation and metastasis.
  • PDLIM2 inhibition suppresses cancer cell proliferation and metastatic characteristics.
  • PDLIM2 represents a promising novel therapeutic target for treating metastatic kidney cancer.
Keywords:
LIM domain proteinsPDLIM2kidney cancerknockout mousemetastasis

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.4K
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K